EAGLE POINT CREDIT CO - ECC 5 3/8 01/31/29 (ECCV) Fundamental Analysis & Valuation

NYSE:ECCV • US2698098850

Current stock price

23.75 USD
-0.08 (-0.34%)
Last:

This ECCV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ECCV Profitability Analysis

1.1 Basic Checks

  • In the past year ECCV was profitable.
  • In the past year ECCV has reported a negative cash flow from operations.
  • In multiple years ECCV reported negative net income over the last 5 years.
  • In the past 5 years ECCV always reported negative operating cash flow.
ECCV Yearly Net Income VS EBIT VS OCF VS FCFECCV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M -300M -400M

1.2 Ratios

  • The 3 year average ROIC (6.75%) for ECCV is below the current ROIC(7.01%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -9.61%
ROE -13.62%
ROIC 7.01%
ROA(3y)2.66%
ROA(5y)2.3%
ROE(3y)3.28%
ROE(5y)3.03%
ROIC(3y)6.75%
ROIC(5y)6.52%
ECCV Yearly ROA, ROE, ROICECCV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • ECCV's Operating Margin has been stable in the last couple of years.
  • ECCV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 60.1%
PM (TTM) N/A
GM 64.04%
OM growth 3Y0.94%
OM growth 5Y1.32%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.53%
GM growth 5Y1.03%
ECCV Yearly Profit, Operating, Gross MarginsECCV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ECCV Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for ECCV has been increased compared to 1 year ago.
  • ECCV has more shares outstanding than it did 5 years ago.
  • ECCV has a worse debt/assets ratio than last year.
ECCV Yearly Shares OutstandingECCV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ECCV Yearly Total Debt VS Total AssetsECCV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • ECCV has an Altman-Z score of 4.58. This indicates that ECCV is financially healthy and has little risk of bankruptcy at the moment.
  • ECCV has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 4.58
ROIC/WACCN/A
WACCN/A
ECCV Yearly LT Debt VS Equity VS FCFECCV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 4.83 indicates that ECCV has no problem at all paying its short term obligations.
  • A Quick Ratio of 4.83 indicates that ECCV has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 4.83
Quick Ratio 4.83
ECCV Yearly Current Assets VS Current LiabilitesECCV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ECCV Growth Analysis

3.1 Past

  • ECCV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.24%.
  • Measured over the past 5 years, ECCV shows a small growth in Earnings Per Share. The EPS has been growing by 0.62% on average per year.
  • ECCV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.92%.
  • The Revenue has been growing by 26.27% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-16.24%
EPS 3YN/A
EPS 5Y0.62%
EPS Q2Q%4.17%
Revenue 1Y (TTM)12.92%
Revenue growth 3Y19.87%
Revenue growth 5Y26.27%
Sales Q2Q%3.36%

3.2 Future

  • The Earnings Per Share is expected to decrease by -5.75% on average over the next years.
  • ECCV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.59% yearly.
EPS Next Y-10.03%
EPS Next 2Y-5.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.87%
Revenue Next 2Y3.59%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ECCV Yearly Revenue VS EstimatesECCV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
ECCV Yearly EPS VS EstimatesECCV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

0

4. ECCV Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 24.23 indicates a rather expensive valuation of ECCV.
  • When comparing the Price/Earnings ratio of ECCV to the average of the S&P500 Index (26.91), we can say ECCV is valued inline with the index average.
  • The Price/Forward Earnings ratio is 26.94, which means the current valuation is very expensive for ECCV.
  • ECCV's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 21.99.
Industry RankSector Rank
PE 24.23
Fwd PE 26.94
ECCV Price Earnings VS Forward Price EarningsECCV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECCV Per share dataECCV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • A cheap valuation may be justified as ECCV's earnings are expected to decrease with -5.75% in the coming years.
PEG (NY)N/A
PEG (5Y)38.85
EPS Next 2Y-5.75%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. ECCV Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.61%, ECCV is a good candidate for dividend investing.
  • Compared to an average S&P500 Dividend Yield of 1.82, ECCV pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.61%

5.2 History

  • The dividend of ECCV has a limited annual growth rate of 5.35%.
  • ECCV has been paying a dividend for over 5 years, so it has already some track record.
  • ECCV has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)5.35%
Div Incr Years0
Div Non Decr Years3
ECCV Yearly Dividends per shareECCV Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • The earnings of ECCV are negative and hence is the payout ratio. ECCV will probably not be able to sustain this dividend level.
DP-155.97%
EPS Next 2Y-5.75%
EPS Next 3YN/A
ECCV Yearly Income VS Free CF VS DividendECCV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

More info and screens

Find the best dividend stocksShow peers with best dividend

ECCV Fundamentals: All Metrics, Ratios and Statistics

EAGLE POINT CREDIT CO - ECC 5 3/8 01/31/29

NYSE:ECCV (4/28/2026, 4:15:00 PM)

23.75

-0.08 (-0.34%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)03-04
Earnings (Next)05-26
Inst Owners8.85%
Inst Owner ChangeN/A
Ins Owners0.3%
Ins Owner ChangeN/A
Market Cap3.14B
Revenue(TTM)203.00M
Net Income(TTM)-134.00M
Analysts76
Price Target31.19 (31.33%)
Short Float %0%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield 5.61%
Yearly Dividend1.71
Dividend Growth(5Y)5.35%
DP-155.97%
Div Incr Years0
Div Non Decr Years3
Ex-Date03-16
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.85%
Min EPS beat(2)1.9%
Max EPS beat(2)13.8%
EPS beat(4)3
Avg EPS beat(4)1.97%
Min EPS beat(4)-11.45%
Max EPS beat(4)13.8%
EPS beat(8)4
Avg EPS beat(8)-3.78%
EPS beat(12)5
Avg EPS beat(12)-7.15%
EPS beat(16)6
Avg EPS beat(16)-6.77%
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-0.05%
Max Revenue beat(2)0.17%
Revenue beat(4)1
Avg Revenue beat(4)-2.97%
Min Revenue beat(4)-11.16%
Max Revenue beat(4)0.17%
Revenue beat(8)2
Avg Revenue beat(8)-2.33%
Revenue beat(12)4
Avg Revenue beat(12)-2.5%
Revenue beat(16)7
Avg Revenue beat(16)-1.68%
PT rev (1m)-12.48%
PT rev (3m)4.09%
EPS NQ rev (1m)-2.8%
EPS NQ rev (3m)-6.52%
EPS NY rev (1m)-2.73%
EPS NY rev (3m)-2.73%
Revenue NQ rev (1m)-0.45%
Revenue NQ rev (3m)-5.66%
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-6.46%
Valuation
Industry RankSector Rank
PE 24.23
Fwd PE 26.94
P/S 15.47
P/FCF N/A
P/OCF N/A
P/B 3.19
P/tB 3.19
EV/EBITDA N/A
EPS(TTM)0.98
EY4.13%
EPS(NY)0.88
Fwd EY3.71%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS1.54
BVpS7.44
TBVpS7.44
PEG (NY)N/A
PEG (5Y)38.85
Graham Number12.8106 (-46.06%)
Profitability
Industry RankSector Rank
ROA -9.61%
ROE -13.62%
ROCE 8.87%
ROIC 7.01%
ROICexc 7.01%
ROICexgc 7.01%
OM 60.1%
PM (TTM) N/A
GM 64.04%
FCFM N/A
ROA(3y)2.66%
ROA(5y)2.3%
ROE(3y)3.28%
ROE(5y)3.03%
ROIC(3y)6.75%
ROIC(5y)6.52%
ROICexc(3y)6.94%
ROICexc(5y)6.77%
ROICexgc(3y)6.95%
ROICexgc(5y)6.78%
ROCE(3y)8.55%
ROCE(5y)8.25%
ROICexgc growth 3Y-5.07%
ROICexgc growth 5Y4.33%
ROICexc growth 3Y-5.07%
ROICexc growth 5Y4.33%
OM growth 3Y0.94%
OM growth 5Y1.32%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.53%
GM growth 5Y1.03%
F-Score4
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 4.36
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.83
Quick Ratio 4.83
Altman-Z 4.58
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.24%
EPS 3YN/A
EPS 5Y0.62%
EPS Q2Q%4.17%
EPS Next Y-10.03%
EPS Next 2Y-5.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.92%
Revenue growth 3Y19.87%
Revenue growth 5Y26.27%
Sales Q2Q%3.36%
Revenue Next Year1.87%
Revenue Next 2Y3.59%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.12%
EBIT growth 3Y21%
EBIT growth 5Y27.94%
EBIT Next Year-4.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y95.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y95.1%
OCF growth 3YN/A
OCF growth 5YN/A

EAGLE POINT CREDIT CO - ECC 5 3/8 01/31/29 / ECCV Fundamental Analysis FAQ

What is the fundamental rating for ECCV stock?

ChartMill assigns a fundamental rating of 3 / 10 to ECCV.


What is the valuation status for ECCV stock?

ChartMill assigns a valuation rating of 0 / 10 to EAGLE POINT CREDIT CO - ECC 5 3/8 01/31/29 (ECCV). This can be considered as Overvalued.


How profitable is EAGLE POINT CREDIT CO - ECC 5 3/8 01/31/29 (ECCV) stock?

EAGLE POINT CREDIT CO - ECC 5 3/8 01/31/29 (ECCV) has a profitability rating of 2 / 10.


What is the financial health of EAGLE POINT CREDIT CO - ECC 5 3/8 01/31/29 (ECCV) stock?

The financial health rating of EAGLE POINT CREDIT CO - ECC 5 3/8 01/31/29 (ECCV) is 3 / 10.


What is the earnings growth outlook for EAGLE POINT CREDIT CO - ECC 5 3/8 01/31/29?

The Earnings per Share (EPS) of EAGLE POINT CREDIT CO - ECC 5 3/8 01/31/29 (ECCV) is expected to decline by -10.03% in the next year.